Waverton Investment Management Ltd Purchases 357,041 Shares of GE HealthCare Technologies Inc. $GEHC

Waverton Investment Management Ltd lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,056,771 shares of the company’s stock after acquiring an additional 357,041 shares during the quarter. GE HealthCare Technologies accounts for 1.1% of Waverton Investment Management Ltd’s portfolio, making the stock its 26th largest position. Waverton Investment Management Ltd’s holdings in GE HealthCare Technologies were worth $78,264,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth about $25,000. Bogart Wealth LLC lifted its holdings in shares of GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares during the last quarter. Gladwyn Financial Advisors Inc. bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth about $34,000. Game Plan Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after acquiring an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT bought a new stake in shares of GE HealthCare Technologies in the 1st quarter worth about $42,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 1.8%

NASDAQ GEHC opened at $75.61 on Thursday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The company has a market capitalization of $34.44 billion, a price-to-earnings ratio of 15.62, a price-to-earnings-growth ratio of 2.79 and a beta of 1.13. The company’s 50-day simple moving average is $75.12 and its two-hundred day simple moving average is $73.32. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Barclays assumed coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Evercore ISI lifted their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Morgan Stanley lifted their price objective on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Wells Fargo & Company decreased their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.